Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85% Market Closed
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kamada Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Revenue
$158.4m
CAGR 3-Years
26%
CAGR 5-Years
2%
CAGR 10-Years
8%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Revenue
$11m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Revenue
$89.4m
CAGR 3-Years
31%
CAGR 5-Years
437%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Revenue
$99k
CAGR 3-Years
-46%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Revenue
â‚Ş0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Revenue
$598k
CAGR 3-Years
N/A
CAGR 5-Years
64%
CAGR 10-Years
5%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Kamada Ltd's Revenue?
Revenue
158.4m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Revenue amounts to 158.4m USD.

What is Kamada Ltd's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Kamada Ltd have been 26% over the past three years , 2% over the past five years , and 8% over the past ten years .

Back to Top